Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,730
Total Claims
$890K
Drug Cost
353
Beneficiaries
$2,521
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-87%
Opioid rate vs peers
0.3% vs 2.2% avg
+79%
Cost per patient vs peers
$2,521 vs $1,411 avg
+6%
Brand preference vs peers
11.3% vs 10.6% avg
Opioid Prescribing
0.3%
Opioid Rate
26
Opioid Claims
$136
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 975 claims · $692K
Generic: 7,663 claims · $192K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 76 | $115K |
| Sitagliptin Phosphate | 80 | $104K |
| Linagliptin | 31 | $48K |
| Apixaban | 53 | $44K |
| Insulin Glargine,hum.Rec.Anlog | 49 | $36K |
| Sitagliptin Phos/Metformin Hcl | 26 | $26K |
| Darunavir | 12 | $25K |
| Raltegravir Potassium | 12 | $24K |
| Mirabegron | 37 | $24K |
| Insulin Aspart Prot/Insuln Asp | 12 | $21K |
| Empagliflozin | 24 | $20K |
| Fluticasone Propion/Salmeterol | 39 | $18K |
| Linaclotide | 15 | $17K |
| Budesonide/Formoterol Fumarate | 28 | $13K |
| Lipase/Protease/Amylase | 13 | $9,738 |
Prescribing Profile
Patient Profile
70
Avg Age
53%
Female
1.48
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About